Koro in an Israeli Male

1986 ◽  
Vol 149 (4) ◽  
pp. 503-506 ◽  
Author(s):  
Ilan Modai ◽  
Hanan Munitz ◽  
Dov Aizenberg

The Koro syndrome, a “special cultural psychiatric syndrome’, is encountered in South China, Malaysia and Indonesia, especially among people of Chinese origin. There are only eight case reports of Koro from the Western hemisphere. We present a typical primary Koro patient from Israel. Jewish cultural mores are a possible contributory factor.

2010 ◽  
Vol 41 (3) ◽  
pp. 453-461 ◽  
Author(s):  
M. Begum ◽  
P. J. McKenna

BackgroundThe nosological status of olfactory reference syndrome (ORS) is a matter of debate and there is uncertainty as to what treatments are effective.MethodThe world literature was searched for reports of cases of ORS. Clinical, nosological and therapeutic information from cases meeting proposed diagnostic criteria for the disorder was summarized and tabulated.ResultsA total of 84 case reports (52 male/32 female) were found. Age of onset was <20 years in almost 60% of cases. Smell-related precipitating events were recorded in 42%. Most patients could not smell the smell or only did so intermittently. Authors of the reports expressed reservations about the delusional nature of the belief in slightly under half of the cases. Over two-thirds were improved or recovered at follow-up, with the disorder responding to antidepressants and psychotherapy more frequently than to neuroleptics.ConclusionsORS is a primary psychiatric syndrome that does not fit well into its current classification as a subtype of delusional disorder, both in terms of its nosology and its response to treatment.


1981 ◽  
Vol 26 (2) ◽  
pp. 126-129 ◽  
Author(s):  
Declan Quinn

The Capgras syndrome is reviewed and two case reports are described. While the Capgras syndrome is frequently considered to be a rather rare psychiatric syndrome, the author questions this and feels that the syndrome is more common than previously thought. Original explanations of this syndrome usually involved dynamic interpretations, but recently there have been many reports to suggest an organic lesion as being the main contributing factor. The mechanism involved seems to be a generalized dysfunction of the non-dominant cerebral hemisphere. It is suggested that any patient presenting with this syndrome be thoroughly evaluated for an underlying organic lesion before dynamic interpretations are used to explain this syndrome. Brief mention is made of two other syndromes which also involve misidentification and are also considered to be organic in origin.


2021 ◽  
Vol 12 ◽  
Author(s):  
Niels Hansen ◽  
Charles Timäus

Background: Autoantibody-associated psychiatric syndromes are often distinct from, but might also be part of autoimmune encephalitis. Our article focuses on potential immunotherapy in these patients with a probable autoimmune origin of their psychiatric syndrome.Methods: We searched through PubMed for appropriate articles on immunotherapy in autoantibody-associated psychiatric syndromes between 2010 and 2020 for this narrative review.Results: In line with prior recommendations for autoimmune encephalitis and autoimmune psychosis, we suggest that in patients with a probable autoimmune-based psychiatric syndrome should be given early corticosteroids, intravenous immunoglobulins, or plasmapheresis as first line immunotherapy. If these therapeutic options fail, second-line immunotherapy should be applied within 1 month consisting of rituximab or cyclophosphamide. Maintenance therapy is best for those patients responding to steroids including mycofenolate mofetil or azathioprine. So far, there is evidence from a few retrospective cohort studies supporting the usage of first- and second-line, and maintenance immunotherapies for autoantibody-associated psychiatric syndromes. Some immunological agents are discussed that might exert an effect in autoimmune-based psychiatric syndromes, but the latest evidence is low and derived from case reports or series with autoimmune encephalitis patients.Conclusions: Taken together, the immunotherapeutic landscape for patients with autoantibody-associated psychiatric syndromes is delineated. Our suggestions rely on observational studies in autoantibody-associated psychiatric syndromes and a few placebo-controlled, randomized trials for patients with autoimmune encephalitis and psychosis. Thus, adequate powered, prospective as well as placebo-controlled clinical trials in patients with autoantibody-associated psychiatric syndromes are warranted in order to enlighten efficacy and safety aspects of current and novel therapy strategies.


2011 ◽  
Vol 45 (12) ◽  
pp. 10
Author(s):  
SHERRY BOSCHERT
Keyword(s):  

VASA ◽  
2018 ◽  
Vol 47 (4) ◽  
pp. 273-277
Author(s):  
Christopher Lowe ◽  
Oussama El Bakbachi ◽  
Damian Kelleher ◽  
Imran Asghar ◽  
Francesco Torella ◽  
...  

Abstract. The aim of this review was to investigate presentation, aetiology, management, and outcomes of bowel ischaemia following EVAR. We present a case report and searched electronic bibliographic databases to identify published reports of bowel ischaemia following elective infra-renal EVAR not involving hypogastric artery coverage or iliac branch devices. We conducted our review according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement standards. In total, five cohort studies and three case reports were included. These studies detailed some 6,184 infra-renal elective EVARs, without procedure-related occlusion of the hypogastric arteries, performed between 1996 and 2014. Bowel ischaemia in this setting is uncommon with an incidence ranging from 0.5 to 2.8 % and includes a spectrum of severity from mucosal to transmural ischaemia. Due to varying reporting standards, an overall proportion of patients requiring bowel resection could not be ascertained. In the larger series, mortality ranged from 35 to 80 %. Atheroembolization, hypotension, and inferior mesenteric artery occlusion were reported as potential causative factors. Elderly patients and those undergoing prolonged procedures appear at higher risk. Bowel ischaemia is a rare but potentially devastating complication following elective infra-renal EVAR and can occur in the setting of patent mesenteric vessels and hypogastric arteries. Mortality ranges from 35 to 80 %. Further research is required to identify risk factors and establish prophylactic measures in patients that have an increased risk of developing bowel ischaemia after standard infra-renal EVAR.


VASA ◽  
2010 ◽  
Vol 39 (1) ◽  
pp. 43-53 ◽  
Author(s):  
Grotenhermen

Background: To investigate the hypothesis that cases of arteritis similar to thromboangiitis obliterans (TAO) and associated with the use of cannabis were caused by cannabis or THC (dronabinol), or that cannabis use is a co-factor of TAO. Patients and methods: A systematic review on case reports and the literature on so-called cannabis arteritis, TAO, and cardiovascular effects of cannabinoids was conducted. Results: Fifteen reports with 57 cases of an arteritis associated with the use of cannabis and two additional case series of TAO, in which some patients also used cannabis, were identified. Clinical and pathological features of cannabis-associated arteritis do not differ from TAO and the major risk factor of TAO, tobacco use, was present in most, if not in all of these cases. The proposed pathophysiological mechanisms for the development of an arteritis by cannabis use are not substantiated. Conclusions: The hypothesis of cannabis being a causative factor or co-factor of TAO or an arteritis similar to TAO is not supported by the available evidence. The use of the term “cannabis arteritis” should be avoided until or unless more convincing scientific support is forthcoming.


Swiss Surgery ◽  
1999 ◽  
Vol 5 (6) ◽  
pp. 281-287 ◽  
Author(s):  
Schindele ◽  
Hackenbruch ◽  
Sutter ◽  
Schärer ◽  
Leutenegger

Häufige Frakturen im Bereich der Schulter betreffen je nach Alter die Clavicula oder den proximalen Humerus. Die Indikation zur operativen Stabilisierung ist bei Luxationsfrakturen des lateralen Claviculaendes und bei instabilen und dislozierten Frakturen des proximalen Humerus grosszügig zu stellen. Werden Kirschner-Drähte zur Osteosynthese eingesetzt muss in hohem Masse mit Drahtwanderungen oder Drahtbrüchen gerechnet werden. In mehreren Fällen wird in der Literatur auf diese Komplikation hingewiesen. Anhand von vier Fallbeispielen möchten wir Ursachen und technische Voraussetzungen aufzeigen, die bei dieser operativen Variante zu lebensbedrohlichen Komplikationen durch eine sekundäre Migration führen können. Dies unter Umständen nach Jahren und ohne klinische Symptome. Die Indikation zur Kirschnerdraht-Osteosynthese muss vor allem bei vorliegender Osteoporose zurückhaltend gestellt werden. Regelmässige Kontrollen in der postoperativen Phase werden empfohlen, die Entfernung der Drähte sollte bei konsolidierter Fraktur frühzeitig geplant werden.


Sign in / Sign up

Export Citation Format

Share Document